Having trouble accessing articles? Reset your cache.

Covella Pharmaceuticals Inc., Biogen Idec, Santarus deal

Santarus acquired Covella for $648,000 in cash and stock and will assume about $1.2 million of Covella

Read the full 170 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE